Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Spironolactone for Corticosteroid-Induced Skin Atrophy
NCT01407471Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2011
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of spironolactone in Cutaneous atrophy due to corticosteroids, sponsored by Assistance publique - Hôpitaux de Paris. Started Sep 2011; status: completed.
02
Drugs
spironolactone
03
Conditions
Cutaneous atrophy due to corticosteroids
Beyond the preview
Go deeper on NCT01407471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01407471.